Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2726083 | 0.88 | TSHR (0.39) | TSHRALDH1A1THRB | |
| SCHEMBL2212633 | 0.87 | TSHR (0.50) | TSHRALDH1A1THRB | |
| SCHEMBL14546264 | 0.84 | TSHR (0.47) | TSHRALDH1A1THRB | |
| SCHEMBL3288186 | 0.83 | TSHR (0.36) | TSHRALDH1A1THRB | |
| SCHEMBL28331619 | 0.81 | TSHR (0.35) | TSHRALDH1A1THRB | |
| SCHEMBL17947770 | 0.79 | TSHR (0.42) | TSHRALDH1A1THRB | |
| SCHEMBL12808955 | 0.77 | TSHR (0.55) | TSHRALDH1A1THRB | |
| SCHEMBL11421262 | 0.77 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL42943 | 0.75 | TSHR (0.42) | TSHRALDH1A1THRB | |
| SCHEMBL15015915 | 0.75 | TSHR (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6326417-B1 | CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES | JENERIC/PENTRON INCORPORATED | 2001-12-04 | — | — | US | claimed |
| EP-1973587-B1 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM INC (US) | 2019-02-06 | — | — | EP | disclosed |
| US-9994444-B2 | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | ALLACCEM, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-9957395-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-9212286-B2 | Methods and systems for coating a surface | ALLACCEM, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2125026-B1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM INC (US) | 2014-09-24 | — | — | EP | disclosed |
| US-20130150809-A1 | METHODS AND SYSTEMS FOR COATING A MEDICAL DEVICE | ALLACCEM, INC. | 2013-06-13 | — | — | US | disclosed |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. (US) | 2013-02-14 | — | — | US | disclosed |
| US-8268381-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8222239-B2 | quaternary ammonium compounds, conjugated to polymers, used as microbiocides | ALLACCEM, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20090054528-A1 | Bridged polycyclic compound based compositions for coating oral surfaces in pets | ALLACCEM, INC. | 2009-02-26 | — | — | US | disclosed |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. | 2008-11-06 | — | — | US | disclosed |
| EP-1973587-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | Allaccem, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2008103847-A2 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INCORPORATED (US) | 2008-08-28 | — | — | WO | disclosed |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | ALLACCEM, INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| WO-2007070801-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM, INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| US-6326417-B1 | CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES | JENERIC/PENTRON INCORPORATED | 2001-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054528-A1 | Bridged polycyclic compound based compositions for coating oral surfaces in pets | PAICS, SLC16A8, CAD | TSHR 4724/4885ALDH1A1 653/4885THRB 4687/4885 |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | DNMT1, TET2, POLR1C | TSHR 4830/4885ALDH1A1 2775/4885THRB 4833/4885 |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | TSHR 4747/4885ALDH1A1 1058/4885THRB 4448/4885 |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | DNMT1, TET2, CD14 | TSHR 4651/4885ALDH1A1 2261/4885THRB 4812/4885 |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | TSHR 4747/4885ALDH1A1 1058/4885THRB 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.